Categories AlphaGraphs, Earnings, Health Care
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates.
The company reported worldwide net revenues of $14.46 billion for the June quarter, up 4.3% from the corresponding period of 2023 and above the market’s projection. All operating segments, except the Eye Care division, registered growth.
Net income, adjusted for special items, declined to $2.65 per share in Q2 from $2.91 per share in the year-ago quarter, but topped expectations. On a reported basis, second-quarter profit was $1.37 billion or $0.77 per share, compared to $2.02 billion or $1.14 per share last year.
Prior Performance
Most Popular
Earnings Preview: Can Lennar Corporation (LEN) sustain its uptrend in Q4?
Homebuilder Lennar Corporation (NYSE: LEN) is set to report fourth-quarter results next week, after delivering strong quarterly sales and earnings performance this year. The resilient housing market and interest rate
What to look for when Conagra Brands (CAG) reports Q2 2025 earnings
Shares of Conagra Brands, Inc. (NYSE: CAG) stayed green on Wednesday. The stock has dropped 11% over the past three months. The branded food company is scheduled to report its
Key highlights from Macy’s (M) Q3 2024 earnings results
Macy’s, Inc. (NYSE: M) reported its third quarter 2024 earnings results today. Net sales decreased 2.4% year-over-year to $4.7 billion. Comparable sales were down 2.4% on an owned basis and
